Repository logo
  • English
  • Srpski (lat)
  • Српски
Log In
Have you forgotten your password?
  1. Home
  2. Browse by Author

Browsing by Author "Stajic, Nataša (6602606131)"

Filter results by typing the first few letters
Now showing 1 - 2 of 2
  • Results Per Page
  • Sort Options
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    Associated extrarenal vascular diseases may complicate the treatment and outcome of renovascular hypertension
    (2016)
    Peco-Antic, Amira (7004525216)
    ;
    Stajic, Nataša (6602606131)
    ;
    Krstic, Zoran (6603679391)
    ;
    Bogdanovic, Radovan (7004665744)
    ;
    Miloševski-Lomic, Gordana (20436011000)
    ;
    D Strok Signukic, Milan (57034364500)
    ;
    Paripovic, Dušan (14621764400)
    Aim This studied reviewed renovascular hypertension (RVH) due to renal artery stenosis (RAS) in two Serbian paediatric centres from 2001 to 2013. Methods The patients' demographic data, underlying syndromes, blood pressure (BP), antihypertensive treatments and outcomes were reviewed. Results The incidence of RVH was 1.9 per million children per year during the study period, and there were 25 patients with RAS, aged 10.4 ± 5.2 years. At presentation, their mean blood pressure (BP) standard deviation scores were 6.9 ± 3.4 systolic and 5.2 ± 2.6 diastolic. BP loads on 24-hour ambulatory BP were 88 ± 14% systolic and 80 ± 29% diastolic. We found that 72% had fibromuscular dysplasia and 28% had underlying syndromes. RAS was unilateral in 64% and bilateral in 28%, and 8% had RAS of a single kidney. Antihypertensive treatment included antihypertensive drugs (100%), percutaneous transluminal angioplasty (92%), renal auto-transplantation (16%), surgical revascularisation (12%) and nephrectomy (12%). After 4.4 ± 3.6 years of follow-up, high BP was cured in 40% of the patients and 39.4% of the kidneys and improved in 48% (75.7%), with BP decreases of 20.3 ± 3.7% systolic and 16.3 ± 6.2% diastolic. Conclusion Fibromuscular dysplasia was the most common cause of RVH in this study, and hypertension was cured or improved in 88% of the patients. ©2015 Foundation Acta Pædiatrica. Published by John Wiley & Sons Ltd.
  • Loading...
    Thumbnail Image
    Some of the metrics are blocked by your 
    consent settings
    Publication
    The multifaceted phenotypic and genotypic spectrum of type-IV-collagen-related nephropathy—A human genetics department experience
    (2022)
    Ćomić, Jasmina (57896737200)
    ;
    Riedhammer, Korbinian M. (57200625458)
    ;
    Günthner, Roman (6507490502)
    ;
    Schaaf, Christian W. (59886124500)
    ;
    Richthammer, Patrick (23983315500)
    ;
    Simmendinger, Hannes (57897933000)
    ;
    Kieffer, Donald (57897456500)
    ;
    Berutti, Riccardo (24483074500)
    ;
    Tasic, Velibor (7003911066)
    ;
    Abazi-Emini, Nora (57896737400)
    ;
    Nushi-Stavileci, Valbona (57193881397)
    ;
    Putnik, Jovana (14008113300)
    ;
    Stajic, Nataša (6602606131)
    ;
    Lungu, Adrian (35812503300)
    ;
    Gross, Oliver (21934239600)
    ;
    Renders, Lutz (6602849386)
    ;
    Heemann, Uwe (26643385000)
    ;
    Braunisch, Matthias C. (57192699344)
    ;
    Meitinger, Thomas (57215631099)
    ;
    Hoefele, Julia (57196082805)
    Disease-causing variants in COL4A3-5 are associated with type-IV-collagen-related nephropathy, a genetically and phenotypically multifaceted disorder comprising Alport syndrome (AS) and thin basement membrane nephropathy (TBMN) and autosomal, X-linked and a proposed digenic inheritance. Initial symptoms of individuals with AS are microscopic hematuria followed by proteinuria leading to kidney failure (90% on dialysis < age 40 years). In contrast, individuals with TBMN, an outdated histology-derived term, present with microscopic hematuria, only some of them develop kidney failure (>50 years of age). An early diagnosis of type-IV-collagen-related nephropathy is essential for optimized therapy and slowing of the disease. Sixty index cases, in whom exome sequencing had been performed and with disease-causing variant(s) in COL4A3-5, were evaluated concerning their clinical tentative diagnosis and their genotype. Of 60 reevaluated individuals with type-IV-collagen-related nephropathy, 72% had AS, 23% TBMN and 5% focal segmental glomerulosclerosis (FSGS) as clinical tentative diagnosis. The FSGS cases had to be re-classified as having type-IV-collagen-related nephropathy. Twelve percent of cases had AS as clinical tentative diagnosis and a monoallelic disease-causing variant in COL4A3/4 but could not be classified as autosomal dominant AS because of limited or conflicting clinical data. This study illustrates the complex clinical and genetic picture of individuals with a type IV-collagen-related nephropathy indicating the need of a refined nomenclature and the more interdisciplinary teamwork of clinicians and geneticists as the key to optimized patient care. Copyright © 2022 Ćomić, Riedhammer, Günthner, Schaaf, Richthammer, Simmendinger, Kieffer, Berutti, Tasic, Abazi-Emini, Nushi-Stavileci, Putnik, Stajic, Lungu, Gross, Renders, Heemann, Braunisch, Meitinger and Hoefele.

Built with DSpace-CRIS software - Extension maintained and optimized by 4Science

  • Privacy policy
  • End User Agreement
  • Send Feedback